Ossiam Insulet Corp Transaction History

Ossiam

$5.1 Billion
Q3 2024

A detailed history of Ossiam transactions in Insulet Corp stock. As of the latest transaction made, Ossiam holds 3,589 shares of PODD stock, worth $981,483. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,589

Previous 2,346 52.98%

Holding current value

$981,483

Previous $473,000 76.53%

% of portfolio

0.02%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$180.69 - $239.01 $224,597 - $297,089	1,243 Added 52.98%	3,589 $835,000
Q2 2024 Aug 13, 2024	BUY	$161.02 - $206.98 $10,788 - $13,867	67 Added 2.94%	2,346 $473,000
Q1 2024 May 13, 2024	SELL	$163.6 - $209.11 $594,522 - $759,905	-3,634 Reduced 61.46%	2,279 $390,000
Q4 2023 Feb 13, 2024	BUY	$127.77 - $221.42 $274,066 - $474,945	2,145 Added 56.93%	5,913 $1.28 Million
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $309,494 - $582,070	2,001 Added 113.24%	3,768 $600,000
Q2 2023 Aug 11, 2023	BUY	$272.48 - $330.23 $163,488 - $198,138	600 Added 51.41%	1,767 $509,000
Q1 2023 May 12, 2023	BUY	$276.36 - $326.03 $135,416 - $159,754	490 Added 72.38%	1,167 $372,000
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $152,054 - $190,541	677 New	677 $155,000
Q1 2022 May 13, 2022	SELL	$194.8 - $275.7 $1.15 Million - $1.63 Million	-5,906 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$255.32 - $318.29 $1.51 Million - $1.88 Million	5,906 New	5,906 $1.57 Million
Q2 2021 Aug 13, 2021	SELL	$225.52 - $304.06 $807,812 - $1.09 Million	-3,582 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$235.95 - $293.05 $2.07 Million - $2.58 Million	-8,787 Reduced 71.04%	3,582 $935,000
Q4 2020 Feb 12, 2021	BUY	$215.97 - $265.89 $2.67 Million - $3.29 Million	12,369 New	12,369 $3.16 Million

Others Institutions Holding PODD

# of Institutions

687

Shares Held

62.7M

Call Options Held

640K

Put Options Held

881K

View Full List

About INSULET CORP

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

More about PODD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account